LEXINGTON, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at Oppenheimer & Company’s 22nd Annual Healthcare Conference at 3:55 p.m. EST on Tuesday, December 13, 2011, in New York City.
